Clinical Trials

Showing trials with last updates posted in 2024.

NCT04450069 | COMPLETED | PHASE1
18 participants

CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies

Study Type:
INTERVENTIONAL
Last Updated:
2024-08-20
Start Date:
2020-08-14
Completion:
2024-05-06
Conditions
  • Relapsed/Refractory B-cell Lymphomas
  • Diffuse Large B Cell Lymphoma (DLBCL)
  • Follicular Lymphoma (FL)
  • Chronic Lymphocytic Leukemia (CLL)
  • Marginal Zone Lymphoma (MZL)
  • Mantle Cell Lymphoma
  • Small Lymphocytic Lymphoma (SLL)
  • Primary Mediastinal Large B Cell Lymphoma
  • Transformed Follicular Lymphoma
  • Waldenstrom Macroglobulinemia
  • Lymphoplasmacytic Lymphoma
  • Burkitt Lymphoma
Interventions
  • COMBINATION_PRODUCT
No Results Yet
NCT04042415 | ACTIVE_NOT_RECRUITING | NA
93 participants

Calorie Restriction in Multiple Sclerosis

Study Type:
INTERVENTIONAL
Last Updated:
2024-08-20
Start Date:
2020-07-14
Completion:
2025-09-30
Conditions
  • Multiple Sclerosis, Relapsing-Remitting
  • Caloric Restriction
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page